CLINICAL_TRIALS
trial_result
· 2016-03-24
Clinical Trial Update: Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome [Phase 3]
Summary
Phase 3 trial evaluating pectin supplementation for diarrhea-predominant irritable bowel syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanjing PLA General Hospital | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED